Your browser doesn't support javascript.
loading
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel.
Yokom, Daniel W; Stewart, John; Alimohamed, Nimira S; Winquist, Eric; Berry, Scott; Hubay, Stacey; Lattouf, Jean-Baptiste; Leonard, Helene; Girolametto, Carla; Saad, Fred; Sridhar, Srikala S.
Affiliation
  • Yokom DW; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Stewart J; Sanofi Canada, Montreal, QC, Canada.
  • Alimohamed NS; Tom Baker Cancer Centre, Calgary, ON, Canada.
  • Winquist E; London Health Sciences Centre, London, ON, Canada.
  • Berry S; Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, Canada.
  • Hubay S; Grand River Regional Cancer Centre, Kitchener, ON, Canada.
  • Lattouf JB; Division or Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
  • Leonard H; CHUM Notre-Dame Hospital, Montreal, QC, Canada.
  • Girolametto C; Grand River Regional Cancer Centre, Kitchener, ON, Canada.
  • Saad F; Division or Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
  • Sridhar SS; Princess Margaret Cancer Centre, Toronto, ON, Canada.
Can Urol Assoc J ; 12(8): E365-E372, 2018 Aug.
Article in En | MEDLINE | ID: mdl-29629866
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Can Urol Assoc J Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Can Urol Assoc J Year: 2018 Document type: Article Affiliation country: Country of publication: